» Articles » PMID: 37189878

Respiratory Syncytial Virus Outbreak in Infants and Young Children During COVID-19 Pandemic in Taiwan

Overview
Specialty Health Services
Date 2023 May 16
PMID 37189878
Authors
Affiliations
Soon will be listed here.
Abstract

Respiratory syncytial virus (RSV) is a major burden of disease in babies and young children, including hospitalizations and deaths. RSV is a seasonal disease that peaks when temperatures decrease in temperate zones and humidity increases in tropical regions. Existing research reveals that RSV hospitalization activity is year-round in Taiwan, which is a subtropical region with small peaks in spring and fall. The monthly distribution and COVID-19 pandemic impact were unclear. The aim of this study was to investigate Taiwan's RSV hospitalization seasonality and the COVID-19 pandemic effects. The National Health Insurance Database and Death Registration Files from the Center for Health and Welfare Data Science Center were connected to birth data for this study. RSV hospitalization (RSVH) in infants aged 0-1 years ranged from 0.9518% (2009) to 1.7113% (2020), substantially higher than in children aged 1-5. Most years had 2 or 3 RSV epidemic seasons in 0-5-year-olds over the 13-year follow-up. RSVH incidence was low until the autumn of 2020, when a major rise occurred after September and lasted until December 2020. We detected RSVH peaks in February-May and July-August. The 2020 RSV outbreak was found at the end of 2020.

Citing Articles

Exploring the epidemiological burden of RSV pre- and post-COVID-19 pandemic: A Jordanian tertiary hospital experience.

Al-Zayadneh E, Marie D, Khraisat F, Musa S, AlSamhori J, Altamimi D J Int Med Res. 2024; 52(12):3000605241306405.

PMID: 39719069 PMC: 11683821. DOI: 10.1177/03000605241306405.

References
1.
Boyce T, Mellen B, Mitchel Jr E, Wright P, Griffin M . Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr. 2000; 137(6):865-70. DOI: 10.1067/mpd.2000.110531. View

2.
Hall C, Weinberg G, Blumkin A, Edwards K, Staat M, Schultz A . Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013; 132(2):e341-8. DOI: 10.1542/peds.2013-0303. View

3.
Li Y, Wang X, Blau D, Caballero M, Feikin D, Gill C . Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022; 399(10340):2047-2064. PMC: 7613574. DOI: 10.1016/S0140-6736(22)00478-0. View

4.
Chi H, Chang I, Tsai F, Huang L, Shao P, Chiu N . Epidemiological study of hospitalization associated with respiratory syncytial virus infection in Taiwanese children between 2004 and 2007. J Formos Med Assoc. 2011; 110(6):388-96. DOI: 10.1016/S0929-6646(11)60057-0. View

5.
Qiu W, Zheng C, Huang S, Zhang Y, Chen Z . Epidemiological Trend of RSV Infection Before and During COVID-19 Pandemic: A Three-Year Consecutive Study in China. Infect Drug Resist. 2022; 15:6829-6837. PMC: 9717604. DOI: 10.2147/IDR.S388231. View